Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer

Qiannan Zhu,1 Jue Wang,1 Yuenian Shi,2 Xiaoming Zha,1 Shui Wang1 1The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People’s Republic of China; 2Nanjing Medical University, Nanjing, Jiangsu, 210029, People’s Republic of ChinaCorrespondence: Shui Wang; Xiaoming Zha, The Fi...

Full description

Bibliographic Details
Main Authors: Zhu Q, Wang J, Shi Y, Zha X, Wang S
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/bioinformatics-prediction-and-in-vivo-verification-identify-slc7a5-as--peer-reviewed-fulltext-article-CMAR
_version_ 1811276863244337152
author Zhu Q
Wang J
Shi Y
Zha X
Wang S
author_facet Zhu Q
Wang J
Shi Y
Zha X
Wang S
author_sort Zhu Q
collection DOAJ
description Qiannan Zhu,1 Jue Wang,1 Yuenian Shi,2 Xiaoming Zha,1 Shui Wang1 1The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People’s Republic of China; 2Nanjing Medical University, Nanjing, Jiangsu, 210029, People’s Republic of ChinaCorrespondence: Shui Wang; Xiaoming Zha, The First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210000, People’s Republic of China, Email ws0801@hotmail.com; njzhaxm@njmu.edu.cnPurpose: Solute carrier family 7, member 5 (SLC7A5) is reportedly a key gene in various tumors. However, the relationship between SLC7A5 and immune cell infiltration in breast cancer remains elusive. In this study, we investigated the expression levels and clinical value of SLC7A5 using the R package in breast cancer through the TCGA database.Methods: Public transcript data and clinical information of patients were downloaded from the TCGA database. Prognosis analysis was performed to explore the clinical value of SLC7A5 as well as drug sensitivity prediction and Gene Set Enrichment Analysis (GSEA). We also explored the correlations between SLC7A5 and immune infiltration as well as immune markers.Results: We observed that high SLC7A5 expression levels were related to poor survival. Our GSEA demonstrated that G protein-coupled receptor-ligand binding, interleukin signaling, neutrophil degranulation, amino acid and derivative metabolism, and Rho GTPase signaling were differentially enriched in the SLC7A5 high-expression phenotype. Patients in the low SLC7A5 expression group showed sensitivity to paclitaxel and doxorubicin.Conclusion: SLC7A5 could serve as a biomarker for breast cancer prognosis.Keywords: SLC7A5, breast cancer, immune cell infiltration, chemosensitivity
first_indexed 2024-04-13T00:05:26Z
format Article
id doaj.art-15975ef9cae2480c9c2ad495e7dbc170
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-04-13T00:05:26Z
publishDate 2022-08-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-15975ef9cae2480c9c2ad495e7dbc1702022-12-22T03:11:14ZengDove Medical PressCancer Management and Research1179-13222022-08-01Volume 142545255977728Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast CancerZhu QWang JShi YZha XWang SQiannan Zhu,1 Jue Wang,1 Yuenian Shi,2 Xiaoming Zha,1 Shui Wang1 1The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People’s Republic of China; 2Nanjing Medical University, Nanjing, Jiangsu, 210029, People’s Republic of ChinaCorrespondence: Shui Wang; Xiaoming Zha, The First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210000, People’s Republic of China, Email ws0801@hotmail.com; njzhaxm@njmu.edu.cnPurpose: Solute carrier family 7, member 5 (SLC7A5) is reportedly a key gene in various tumors. However, the relationship between SLC7A5 and immune cell infiltration in breast cancer remains elusive. In this study, we investigated the expression levels and clinical value of SLC7A5 using the R package in breast cancer through the TCGA database.Methods: Public transcript data and clinical information of patients were downloaded from the TCGA database. Prognosis analysis was performed to explore the clinical value of SLC7A5 as well as drug sensitivity prediction and Gene Set Enrichment Analysis (GSEA). We also explored the correlations between SLC7A5 and immune infiltration as well as immune markers.Results: We observed that high SLC7A5 expression levels were related to poor survival. Our GSEA demonstrated that G protein-coupled receptor-ligand binding, interleukin signaling, neutrophil degranulation, amino acid and derivative metabolism, and Rho GTPase signaling were differentially enriched in the SLC7A5 high-expression phenotype. Patients in the low SLC7A5 expression group showed sensitivity to paclitaxel and doxorubicin.Conclusion: SLC7A5 could serve as a biomarker for breast cancer prognosis.Keywords: SLC7A5, breast cancer, immune cell infiltration, chemosensitivityhttps://www.dovepress.com/bioinformatics-prediction-and-in-vivo-verification-identify-slc7a5-as--peer-reviewed-fulltext-article-CMARslc7a5breast cancerimmune cell infiltrationchemosensitivity
spellingShingle Zhu Q
Wang J
Shi Y
Zha X
Wang S
Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer
Cancer Management and Research
slc7a5
breast cancer
immune cell infiltration
chemosensitivity
title Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer
title_full Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer
title_fullStr Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer
title_full_unstemmed Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer
title_short Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer
title_sort bioinformatics prediction and in vivo verification identify slc7a5 as immune infiltration related biomarker in breast cancer
topic slc7a5
breast cancer
immune cell infiltration
chemosensitivity
url https://www.dovepress.com/bioinformatics-prediction-and-in-vivo-verification-identify-slc7a5-as--peer-reviewed-fulltext-article-CMAR
work_keys_str_mv AT zhuq bioinformaticspredictionandinvivoverificationidentifyslc7a5asimmuneinfiltrationrelatedbiomarkerinbreastcancer
AT wangj bioinformaticspredictionandinvivoverificationidentifyslc7a5asimmuneinfiltrationrelatedbiomarkerinbreastcancer
AT shiy bioinformaticspredictionandinvivoverificationidentifyslc7a5asimmuneinfiltrationrelatedbiomarkerinbreastcancer
AT zhax bioinformaticspredictionandinvivoverificationidentifyslc7a5asimmuneinfiltrationrelatedbiomarkerinbreastcancer
AT wangs bioinformaticspredictionandinvivoverificationidentifyslc7a5asimmuneinfiltrationrelatedbiomarkerinbreastcancer